Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:
  • Enrolling by invitation  
  • « Prev · Page 66

NCT ID: NCT00914758 Enrolling by invitation - Clinical trials for Relapsing Remitting Multiple Sclerosis

Comparison of Campath and Rebif Treatment on Cognition in Multiple Sclerosis (MS)

Start date: March 2009
Phase: N/A
Study type: Observational

People with multiple sclerosis (MS) often experience problems with cognitive functioning, which can be debilitating and interfere with their daily functioning. However, research has shown that MS disease modifying agents have had some success in treating cognitive problems. The main purpose of this research study is to investigate how well two medicines (alemtuzumab (Campath®) and interferon beta-1a (Rebif®)) work in treating MS-related cognitive problems (e.g., attention, memory, speed of thinking). Participants enrolled will be assessed prior to their first study-related medication dose and re-assessed throughout treatment. It is expected that participants taking Campath® will demonstrate relative stability in cognitive functioning relative to those taking Rebif®. Specifically, the cognitive performance of Rebif® participants will decline somewhat over time, but the cognitive performance of Campath® participants will remain stable.

NCT ID: NCT00901316 Enrolling by invitation - Clinical trials for Community-Acquired Staphylococcus Aureus

Prevention of Recurrent Infections Caused by Community Acquired Staphylococcus Aureus (CA-SA) in Children

Start date: June 2009
Phase: N/A
Study type: Interventional

The primary purpose of this study is to determine if adding bleach baths to routine ways for prevention of Staph infections is helpful. The amount added is a very weak amount. This would provide a relatively inexpensive method to help prevent recurrent skin infections caused by the Staph germ. The investigators will also be studying how often Staphylococcus aureus lives in the nose, throat, and groin area.

NCT ID: NCT00822289 Enrolling by invitation - Hyperthyroidism Clinical Trials

The Effect of Radioactive Iodine Administration for Thyroid Diseases on H.Pylori Eradication

Start date: February 2009
Phase: N/A
Study type: Observational

Because of the high iodine uptake in the stomach, radioactive iodine treatment for thyroid diseases (cancer or hyperthyroidism) or radioactive iodine administered for thyroid scan may be able to eradicate H.pylori infection from the stomach of patients infected with H.pylori. Also to test the hypothesis that CagA virulent strains of H.pylori are more common in patients with thyroid cancer than with other thyroid diseases.

NCT ID: NCT00778440 Enrolling by invitation - Chronic Disease Clinical Trials

Risk Level of Suffering From Traffic Injury in Primary Health Care: LESIONAT Project

LESIONAT
Start date: January 2009
Phase: N/A
Study type: Observational

Main objectives: - To know the distribution of risk elements of traffic injuries Secondary objectives: - To study the distribution of risk elements related with the possibility of suffering from a TI in relation to medication, chronic health problems, and consumption of psychoactive substances (alcohol and others). - To know the relation between levels of perception of risk of suffering from a TI and the presence of chronic problems, medications, or consumption of psychoactive substances.

NCT ID: NCT00770627 Enrolling by invitation - Clinical trials for Attention Deficit Hyperactivity Disorder

Clinical Trial to Evaluate the Efficacy and the Tolerance of an Omega 3 Fatty Acids Supplementation in ADHD Children

Start date: October 2008
Phase: Phase 4
Study type: Interventional

Principal focus is to evaluate the effects of omega 3 fatty acids supplementation on the ADHD children's behaviour during 12 weeks on two years. The secondary focus is to evaluate the effects of omega 3 fatty acids supplementation on the lexical level,intentional abilities, anxiety and depression. The omega 3 fatty acids don't present adverse side effects. The inclusion to the trial could avoid the intake the methylphenidate and its associated adverse side effects.

NCT ID: NCT00758212 Enrolling by invitation - HIV Infections Clinical Trials

Influenza Vaccination at a Reduced Dose Using Mesotherapy in HIV/AIDS Patients at the Hadassah AIDS Center, Jerusalem

Start date: November 2008
Phase: N/A
Study type: Interventional

Influenza vaccination has proved it's effectiveness over many years of usage including HIV/AIDS patients who are immunocompromised. In those patients, however, a noted rise in HIV viral load which follows intramuscular injection of the vaccine is of unknown significance over the long run. Mesotherapy is a procedure developed and practiced in france by which a reduced and diluted amounts of antigens is being introduced by multiple intradermal injections over the torso and upper back. Mesotherapy is mainly used as a vehicle for introducing pain medicine and cosmetics.

NCT ID: NCT00623168 Enrolling by invitation - Clinical trials for Hemorrhagic Fever With Renal Syndrome

Ribavirin for Hemorrhagic Fever With Renal Syndrome

Start date: February 2008
Phase: Phase 2
Study type: Interventional

Hemorrhagic Fever with Renal Syndrome (HFRS) is caused by a virus acquired by contact with chronically infected rodent hosts. HFRS is present throughout Korea. Treatment consists mainly of supportive care with careful attention to control of blood pressure and fluid balance and/or dialysis. Early initiation of IND Intravenous Ribavirin has been shown to be an effective treatment for HFRS and may prevent the need for dialysis. It is important to initiate therapy based on a diagnosis consistent with HFRS and a history that makes exposure likely. This study will monitor the clinical events that occur with HFRS as well as the safety and efficacy of Ribavirin.

NCT ID: NCT00583817 Enrolling by invitation - Aortic Dissection Clinical Trials

Endovascular Treatment of Thoracic Aortic Disease

EVOLVE Aorta
Start date: October 25, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the role endovascular therapy to treat aortic disease involving the ascending aorta, the aortic arch, and the visceral segment of the aorta (or thoracoabdominal aorta)

NCT ID: NCT00001620 Enrolling by invitation - Healthy Volunteer Clinical Trials

Screening for Hematology Branch Protocols

Start date: December 31, 1996
Phase:
Study type: Observational

This study allows the evaluation of subjects in order to determine their ability to safely participate in other active research studies. After subjects complete the screening process, they will be offered the opportunity to participate in an active research study, or if no appropriate studies are available information and recommendations will be provided for other treatment options.